VivoSim Labs VIVS
NASDAQ VIVS
$0.17 +0.01 (+7.80%)
At close: Oct 20, 2026 · 4:00 PM EDT

VivoSim Labs (VIVS) Asset Writedowns and Impairment (2019 - 2024)

Updated

VivoSim Labs' Asset Writedowns and Impairment was $798,000 in FY2025 (year ended Mar 31, 2025).

Analysis

VivoSim Labs (VIVS) Asset Writedowns and Impairment (2019 - 2024) Analysis & Trends

  • Asset Writedowns and Impairment shows a five-year compound annual growth rate of 30.1% (FY2020 to FY2025).
  • The FY2025 figure marks the lowest annual Asset Writedowns and Impairment since FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.45 Bn 36.15 Bn 1.44 Bn
2 Medpace Holdings 17.53 Bn 15.59 Bn 201.64 Mn
3 Charles River Laboratories International 15.19 Bn 14.39 Bn 363.37 Mn
4 Icon 13.68 Bn 10.79 Bn 479.29 Mn
5 Fortrea Holdings 2.17 Bn 1.54 Bn 139.20 Mn
6 Ginkgo Bioworks Holdings 614.73 Mn -147.35 Mn 18.44 Mn
7 Evotec SE 529.18 Mn -1.08 Bn -
8 Champions Oncology 66.43 Mn 41.52 Mn 7.70 Mn
9 MindWalk Holdings 59.60 Mn 23.25 Mn 1.61 Mn
10 VivoSim Labs 905,903.01 -16.82 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 600,000.00
Sep 30, 2019 200,000.00
API Access

VivoSim Labs Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=VIVS&period=max&api_key=YOUR_API_KEY